MedPath
TGA Approval

LUCENTIS ranibizumab (rbe) 2.3 mg/0.23 mL solution for injection vial (148325)

148325

LUCENTIS ranibizumab (rbe) 2.3 mg/0.23 mL solution for injection vial

Novartis Pharmaceuticals Australia Pty Ltd

November 10, 2008

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/81261cdc97e6e5f483af59e5c4c48e23.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/21ee801642d6bf4d4565f233d7e7409a.pdf

Active Ingredients

Ranibizumab

© Copyright 2025. All Rights Reserved by MedPath
LUCENTIS ranibizumab (rbe) 2.3 mg/0.23 mL solution for injection vial (148325) - TGA 批准文号 | MedPath